Sponsors (65)
The bill seeks to improve emergency care for overdoses by establishing evidence-based fentanyl testing guidance and studying cost-effectiveness, but without strong privacy safeguards and cost protections it could raise costs and deter vulnerable patients from seeking care.
Overdose patients treated in emergency departments would receive clearer, evidence-based fentanyl testing policies that improve diagnosis and enable more tailored treatment.
Clinicians (especially ED providers) would get clearer guidance about which substances are included in routine drug tests, improving informed consent and clinical decision-making.
A required study of the costs and benefits of testing practices could identify cost-effective approaches that reduce unnecessary testing and lower expenses for hospitals and some patients.
Overdose patients—particularly low-income individuals—may avoid seeking emergency care if testing recommendations are implemented without clear protections, increasing risk of worse health outcomes.
Routine fentanyl testing could raise patient privacy and confidentiality concerns unless strong safeguards are required.
Hospitals may incur additional administrative and testing costs if guidance encourages routine fentanyl testing, which could lead to higher charges for some patients.
Based on analysis of 2 sections of legislative text.
Requires HHS to study ED fentanyl testing within 1 year and issue guidance within 6 months after the study on routine testing and clinician information.
Official title: To direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, and for other purposes.
Introduced March 10, 2025 by Ted Lieu · Last progress March 10, 2025
Requires the HHS Secretary to complete a study, within one year of enactment, examining emergency department practices and impacts of fentanyl testing for patients treated for overdose. The study must look at how often EDs test for fentanyl, costs, clinical benefits and risks, and effects on patient experience, privacy, and the patient–physician relationship. Within six months after finishing the study, the Secretary must issue guidance based on the results on whether EDs should routinely implement fentanyl testing, how to inform clinicians about which substances are included in routine tests, and how testing may affect future overdose risk and health outcomes.